NCT04094415 - A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice | Biotech Hunter

Enrollment

581

Participants

Timeline

Start Date

October 28, 2019

Primary Completion Date

July 28, 2021

Study Completion Date

July 28, 2021

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Semaglutide

Patients will be treated with commercially available semaglutide in a prefilled pen injector (FlexTouch® variant) according to routine local clinical practice at the discretion of the treating physician. Other anti-hyperglycaemic treatments will be prescribed at the physician's discretion.The decision to initiate treatment with semaglutide is at the treating physician's discretion, and clearly separated from the decision to include the patient in the study.

Trial Locations (39)

10023

Novo Nordisk Investigational Site, Chieri Torino

10043

Novo Nordisk Investigational Site, Orbassano

16165

Novo Nordisk Investigational Site, Genova

20024

Novo Nordisk Investigational Site, Milan

20089

Novo Nordisk Investigational Site, Rozzano (MI)

20099

Novo Nordisk Investigational Site, Sesto San Giovanni (MI)

20146

Novo Nordisk Investigational Site, Milan

20162

Novo Nordisk Investigational Site, Milan

24022

Novo Nordisk Investigational Site, Bergamo

24030

Novo Nordisk Investigational Site, Bergamo

24047

Novo Nordisk Investigational Site, Treviglio (Bergamo)

27100

Novo Nordisk Investigational Site, Pavia

Novo Nordisk Investigational Site, Vigevano

31100

Novo Nordisk Investigational Site, Treviso

33100

Novo Nordisk Investigational Site, Udine

36061

Novo Nordisk Investigational Site, Vicenza

36100

Novo Nordisk Investigational Site, Vicenza

37024

Novo Nordisk Investigational Site, Negrar (VR)

40138

Novo Nordisk Investigational Site, Bologna

48121

Novo Nordisk Investigational Site, Ravenna

50012

Novo Nordisk Investigational Site, Bagno a Ripoli

57124

Novo Nordisk Investigational Site, Livorno

59100

Novo Nordisk Investigational Site, Prato

62100

Novo Nordisk Investigational Site, Macerata

67051

Novo Nordisk Investigational Site, L’Aquila

70121

Novo Nordisk Investigational Site, Bari

71121

Novo Nordisk Investigational Site, Foggia

72100

Novo Nordisk Investigational Site, Brindisi

73042

Novo Nordisk Investigational Site, Casarano (Lecce)

80059

Novo Nordisk Investigational Site, Napoli

80121

Novo Nordisk Investigational Site, Napoli

80126

Novo Nordisk Investigational Site, Napoli

80138

Novo Nordisk Investigational Site, Napoli

88100

Novo Nordisk Investigational Site, Catanzaro

06024

Novo Nordisk Investigational Site, Cipolleto Perugia

04024

Novo Nordisk Investigational Site, Gaeta

00161

Novo Nordisk Investigational Site, Roma

00186

Novo Nordisk Investigational Site, Roma

00168

Novo Nordisk Investigational Site, Rome